Company Overview
TriStar's unique Tissue Micro Array platform utilizes high-throughput molecular pathology to relate molecular target expression/amplification to annotated clinical data. Thousands of human normal and diseased tissues samples are simultaneously screened on a single array. Focus areas include Cancer and Neurodegenerative diseases. Tissues are collected in accordance with applicable laws and regulations. Repositories located in Hamburg (Germany), Catania (Italy) and Washington DC.
TriStar's repository of over 60,000 micro-arrayed Cancer, CNS & Normal tissues is the largest of its kind in the world today. We provide clinically relevant information about a molecular target early in the drug discovery process to over 60 customers in the United States, Europe, Japan & Australia
New Arrays
- Hormone refractory prostate cancers
- Prostate cancer bone metastases
- NSCLC primary & matched distant metastases
- Pancreatic cancer primary & matched metastases
- Alzheimer's disease
Contract Research Services
- Large scale multi-tumor (>3500 donor samples) & normal human tissue (>600 donor samples) analysis
- Large scale tumor prognosis analysis
- Large-scale analysis of primary tumors and matched metastases
- GLP tissue cross reactivity studies (human, cynomolgus monkey, rat)
- Gene amplification prognosis studies by FISH
- Pharmacological screening services (cell based assays)
- Cardiotoxicity screening of compounds using EHT (engineered heart tissues)